KRAS Variant Screening Assay 20x, 200ul, allows detection of KRAS variants (G12D, G12C, G12A, G12V, and G13D) in various types of biopsies.
KRAS Variant Screening Assay 20x, 200ul or made to order
PRODUCT OVERVIEW
Digital PCR assay for KRAS variants (G12D, G12C, G12A, G12V, and G13D) combines the 5’ nuclease chemistry of 6-fluorescein amidite and hexachloro-fluorescein with digital PCR methodology to provide a sensitive, wet-lab validated solution for quantitative detection of low-frequency mutant alleles in cancer detection.
Overview of sensitive mutation detection using dPCR Assays:
• Optimized dPCR performance—wet lab–verified assays targeting specific cancer mutations
• High specificity—designed to block the wild-type and amplify only the mutant
• High sensitivity—detect and quantify rare mutant prevalence to ≤0.1%
• Cost-effective and convenient—single-tube format includes both wild type and mutant alleles
Contents & Storage1 tube containing a 20X mix of pre-formulated assay. Store at -15 to -25°C.